300765 石药创新
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)38.195-7.5381.1929.42720.105
总资产报酬率 ROA (%)16.833-3.9210.7967.20717.448
投入资产回报率 ROIC (%)30.899-6.7221.1759.29619.722

边际利润分析
销售毛利率 (%)76.74438.37141.97246.07443.210
营业利润率 (%)48.486-25.278-11.02310.30232.575
息税前利润/营业总收入 (%)50.082-25.892-13.3367.15229.111
净利润/营业总收入 (%)47.881-28.240-15.3084.95027.665

收益指标分析
经营活动净收益/利润总额(%)97.534110.770107.09290.39798.794
价值变动净收益/利润总额(%)0.367-0.6990.4014.7991.976
营业外收支净额/利润总额(%)-0.0851.1101.3370.225-0.495

偿债能力分析
流动比率 (X)1.4151.0531.9542.4255.475
速动比率 (X)1.3080.8691.6762.3075.066
资产负债率 (%)49.95855.46325.34326.61813.958
带息债务/全部投入资本 (%)13.892-3.2730.570-1.1991.758
股东权益/带息债务 (%)586.341-2,447.44217,019.336-8,309.9265,537.337
股东权益/负债合计 (%)90.48776.625244.436265.510615.090
利息保障倍数 (X)30.58878.3836.163-2.253-8.811

营运能力分析
应收账款周转天数 (天)25.00263.02064.20061.95155.387
存货周转天数 (天)108.945121.34897.64160.86960.355